Literature DB >> 11296812

Recommendation to standardize pediculicidal and ovicidal testing for head lice (Anoplura: Pediculidae).

C N Burkhart1, C G Burkhart.   

Abstract

Pediculosis capitis is a prevalent and highly communicable condition infesting millions of elementary school students annually. Topical insecticides are the present standard treatment for this condition. Because resistance of head lice to insecticides is a growing concern, assessment of efficacy of pediculicidal and ovicidal activity of the various agents is needed for public health interests. Given the number of anecdotal and market-driven reported studies, assessment of topical lice therapies requires standardized testing. Evaluations based on adaptations of World Health Organization guidelines are not ideal, whereas a protocol reflecting clinical exposure to insecticides is preferable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296812     DOI: 10.1603/0022-2585-38.2.127

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  9 in total

1.  Efficacy of a single treatment of head lice with a neem seed extract: an in vivo and in vitro study on nits and motile stages.

Authors:  Fathy Abdel-Ghaffar; Saleh Al-Quraishy; Khaled A S Al-Rasheid; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2011-06-11       Impact factor: 2.289

2.  Response of Pediculus humanus humanus (Pediculidae: Phthiraptera) to water or 70% ethanol immersion and determination of optimal times for measuring toxic effects.

Authors:  Gastón Mougabure Cueto; María Inés Picollo
Journal:  Parasitol Res       Date:  2010-04-01       Impact factor: 2.289

3.  Identification of repellent odorants to the body louse, Pediculus humanus corporis, in clove essential oil.

Authors:  Takuma Iwamatsu; Daisuke Miyamoto; Hidefumi Mitsuno; Yoshiaki Yoshioka; Takeshi Fujii; Takeshi Sakurai; Yukio Ishikawa; Ryohei Kanzaki
Journal:  Parasitol Res       Date:  2016-02-11       Impact factor: 2.289

4.  Contact and fumigant toxicity of hexane flower bud extract of Syzygium aromaticum and its compounds against Pediculus humanus capitis (Phthiraptera: Pediculidae).

Authors:  Asokan Bagavan; Abdul Abdul Rahuman; Chinnaperumal Kamaraj; Gandhi Elango; Abdul Abduz Zahir; Chidambaram Jayaseelan; Thirunavukkarasu Santhoshkumar; Sampath Marimuthu
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

5.  Ex vivo effectiveness of French over-the-counter products against head lice (Pediculus humanus capitis De Geer, 1778).

Authors:  Catherine Combescot-Lang; Robert H Vander Stichele; Berthine Toubate; Emilie Veirron; Kosta Y Mumcuoglu
Journal:  Parasitol Res       Date:  2015-02-27       Impact factor: 2.289

6.  In vitro screening of anti-lice activity of Pongamia pinnata leaves.

Authors:  John Samuel Anbu Jeba Sunilson; Radhamani Suraj; Gopinath Rejitha; Kalusalingam Anandarajagopal; Anita Gnana Kumari Anbumani Vimala; Hj Azman Husain
Journal:  Korean J Parasitol       Date:  2009-12-02       Impact factor: 1.341

7.  Pediculus humanus capitis (head lice) and Pediculus humanus humanus (body lice): response to laboratory temperature and humidity and susceptibility to monoterpenoids.

Authors:  A Gallardo; G Mougabure Cueto; M I Picollo
Journal:  Parasitol Res       Date:  2009-02-26       Impact factor: 2.289

8.  Safety, Efficacy, and Physicochemical Characterization of Tinospora crispa Ointment: A Community-Based Formulation against Pediculus humanus capitis.

Authors:  Gerwin Louis Tapan Dela Torre; Kerstin Mariae Gonzales Ponsaran; Angelica Louise Dela Peña de Guzman; Richelle Ann Mallapre Manalo; Erna Custodio Arollado
Journal:  Korean J Parasitol       Date:  2017-08-31       Impact factor: 1.341

9.  High efficacy of a dimeticone-based pediculicide following a brief application: in vitro assays and randomized controlled investigator-blinded clinical trial.

Authors:  Jorg Heukelbach; Doerte Wolf; John Marshall Clark; Hans Dautel; Kristina Roeschmann
Journal:  BMC Dermatol       Date:  2019-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.